Unusual Bearish Options Bet Targets Thermo Fisher as Stock Approaches 52-Week High

By TrendSpider Editor

A single unusual put contract on Thermo Fisher Scientific Inc (TMO) is drawing attention Wednesday, with $1,784,250 in premium flowing into a bearish position as the stock trades at $693.32, up 0.80% on the session. The contract represents a notable downside bet on a name that has climbed well above

Unusual Bearish Options Bet Targets Thermo Fisher as Stock Approaches 52-Week High

A single unusual put contract on Thermo Fisher Scientific Inc (TMO) is drawing attention Wednesday, with $1,784,250 in premium flowing into a bearish position as the stock trades at $693.32, up 0.80% on the session. The contract represents a notable downside bet on a name that has climbed well above its 52-week low of $435.27 and is closing in on its 52-week high of $701.64. With the stock sitting just 1.2% below that annual peak, the timing of this options activity raises questions about whether a near-term pullback may be on the horizon.

Key Drivers of the TMO Stock Move

The forward setup for TMO is worth monitoring closely. The stock is pressing against its 52-week high of $701.64, a level that could act as technical resistance. A failure to break above that ceiling in the near term could validate the thesis behind this put position. The 30-day expiration window on November 20, 2026 is tight, and the 4,406% open interest spike makes it difficult to dismiss this as routine hedging activity. Traders should watch whether additional bearish flow emerges or whether call-side activity counters this signal in the days ahead.

TMO Unusual Options Activity

One unusual options contract was flagged on TMO today, Wednesday, October 21, 2026:

The total premium associated with this contract is $1,784,250. The position is currently out of the money with the stock trading at $693.32, requiring a decline of more than $83 per share by expiration for the trade to move in the money. The extreme open interest percentage change is the defining characteristic of this flow, pointing to a deliberate, directional wager rather than routine portfolio management.

TMO Seasonality

Late October and November have historically been a mixed period for large-cap life sciences and laboratory instrumentation names, as third-quarter earnings results digest and investors begin positioning ahead of year-end capital allocation decisions. A one-month put expiring in late November captures that transition window, which adds context to why a trader may be leaning bearish heading into the back half of the fourth quarter.

TMO Relative Performance

TMO's 0.80% gain on Wednesday puts it in positive territory on the session, and its current price of $693.32 reflects a strong recovery from its 52-week low of $435.27, representing a gain of roughly 59% from that trough. The stock is now within striking distance of its 52-week high of $701.64, outperforming many of its peers in the life sciences tools and services space on a trailing basis. However, the proximity to that annual high, combined with today's bearish options flow, may give momentum-focused traders reason to watch price action carefully near the $700 level.

More on TMO

Latest Market News